Nextech Invest Ag Context Therapeutics Inc. Transaction History
Nextech Invest Ag
- $613 Million
- Q3 2024
A detailed history of Nextech Invest Ag transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Nextech Invest Ag holds 7,419,355 shares of CNTX stock, worth $8.46 Million. This represents 2.37% of its overall portfolio holdings.
Number of Shares
7,419,355
Previous 7,419,355
-0.0%
Holding current value
$8.46 Million
Previous $14.8 Million
2.0%
% of portfolio
2.37%
Previous 2.8%
Shares
1 transactions
Others Institutions Holding CNTX
# of Institutions
45Shares Held
56.9MCall Options Held
0Put Options Held
0-
Deep Track Capital, LP Greenwich, CT7.42MShares$8.46 Million0.54% of portfolio
-
Avidity Partners Management LP Dallas, TX7.42MShares$8.46 Million0.89% of portfolio
-
Great Point Partners LLC Greenwich, CT6.93MShares$7.91 Million6.28% of portfolio
-
Blue Owl Capital Holdings LP New York, NY5.41MShares$6.17 Million3.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$4.27 Million0.0% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $18.2M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...